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Abstract
Von Willebrand factor (vWf) is a glycoprotein involved in primary hemostasis and synthesized in endothelial cells (EC).
vWf is stored in secretory granules specific for EC called Weibel^Palade bodies (WPb). Studies on the molecular mechanisms
of vWf storage and acute release are hampered by the limitations of the available endothelial cell culture models. We created
a suitable model by stable transfection of the vWf-negative ECV304 endothelial cell line with pro-vWf cDNA. Pro-vWf was
normally cleaved to mature vWf and stored in WPb. Acute vWf release occurred in response to the calcium ionophore
A23187. Thus, vWf expression is sufficient to restore functional secretory granules in ECV304 cells. We used this model to
study the role of WPb in the storage of tissue-type plasminogen activator (t-PA), a key fibrinolytic enzyme that is acutely
released by EC, but whose intracellular storage compartment is still a matter of debate. We observed that restoration of WPb
in ECV304 cells results in the targeting of t-PA to these storage granules. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
von Willebrand factor (vWf) is a glycoprotein in-
volved in primary hemostasis, i.e. the formation of a
platelet plug at sites of vascular injury [1,2]. vWf is
synthesized by megakaryocytes and endothelial cells.
A better understanding of the mechanisms of acute
vWf release from preformed stores in endothelial
cells is relevant to primary hemostasis, and could
provide insights into regulated secretion in general.
The processing of vWf has been mostly studied in
cultured human umbilical vein endothelial cells (HU-
VEC). vWf is synthesized as a large precursor, pro-
vWf, which undergoes dimerization and glycosyla-
tion as it moves through the endoplasmic reticulum
and the Golgi apparatus. When it reaches the trans-
Golgi network, pro-vWf undergoes multimerization
and endoproteolytic cleavage, resulting in the gener-
ation of mature vWf (2050 amino acids) and an un-
usually large propeptide (741 amino acids). The two
moieties are then either released constitutively or
packaged into endothelial-speci¢c secretory granules
called Weibel^Palade bodies (WPb). These secretory
granules are easily identi¢ed by electron microscopy
or by immuno£uorescence by their typical elongated
rod-like shape. Mature vWf is stored as high molec-
ular weight multimers, together with the propeptide
in a 1:1 molar ratio [1,2].
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The mechanisms of WPb biogenesis are still in-
completely understood. Transfection of pro-vWf
cDNA into heterologous, neuroendocrine secretory
cells resulted in the generation of WPb-like struc-
tures, which were distinct from the storage granules
of the endogenous regulated secretory proteins (insu-
lin in RIN-m5F cells and ACTH in AtT-20 cells) [3].
Pro-vWf transfection even induced the formation of
WPb-like structures in CV-1 kidney cells, which are
not known to have a regulated secretory pathway [4].
It should be emphasized that in these transfection
experiments, vWf-containing granules were identi¢ed
by morphological criteria, but not by acute release
studies [3,4].
In HUVEC, vWf is acutely released in response to
several agonists, such as thrombin and histamine [1].
A rise in intracellular calcium is essential for exocy-
tosis [5]. In addition, cAMP-raising agents, such as
forskolin, epinephrine and adenosine induce vWf re-
lease and potentiate the secretory response to calci-
um-mobilizing agents [6,7].
The limitations of the available endothelial cell
culture models have hampered the detailed analysis
of the molecular mechanisms of WPb biogenesis and
exocytosis. HUVEC are often used, but are di⁄cult
to grow in large amounts because of their limited life
span. Furthermore, many laboratories have found
those cells di⁄cult to transfect. Established endothe-
lial cell lines are easier to transfect, but no longer
express pro-vWf. The ECV304 endothelial cell line,
an easily transfectable spontaneously transformed
cell line established from HUVEC has been used to
study a variety of endothelial functions [8]. However,
these cells do not express pro-vWf and therefore do
not contain WPb. For studying the mechanisms of
secretion from WPb, we have generated a stable
ECV304-derived cell line that expresses pro-vWf.
We observed that pro-vWf expression was su⁄cient
to restore the formation of functional WPb in
ECV304 cells.
Many of the stimuli that induce vWf release also
induce the acute release of tissue-type plasminogen
activator (t-PA), a key enzyme for the removal of
intravascular ¢brin deposits. The identity of the in-
tracellular storage site for t-PA in EC is still a matter
debate, with evidence in favor of storage in WPb [9]
or in distinct storage granules [10]. We used the pro-
vWf expressing ECV304-derived cell line to deter-
mine whether the presence of WPb plays a role in
the pattern of storage of t-PA. We observed that
restoration of WPb in ECV304 cells leads to the
targeting of t-PA to these granules.
2. Materials and methods
2.1. Materials
Biochemical reagents were from Sigma (St. Louis,
MO) or from Fluka (Buchs, Switzerland). RPMI
1640, fetal calf serum and collagenase were from Se-
romed (Berlin, Germany). Tissue culture dishes were
from Costar (Cambridge, MA). Endothelial cell
growth supplement (ECGS) was from Upstate Bio-
technology (Lake Placid, NY). Human thrombin,
forskolin, A23187 and IBMX (3-isobutyl-1-methyl-
xanthine) were from Sigma (St. Louis, MO). Rabbit
anti-vWf antibodies were from Dako (Glostrup,
Denmark). The monoclonal antibody to the propep-
tide of vWf (3H4) has previously been described [11].
The monoclonal anti-t-PA antibody ESP-4 was from
American Diagnostica (Greenwich, CT). The BB6
(anti-LAMP1) monoclonal antibody was kindly pro-
vided by Dr. M. Fukuda (La Jolla, CA). Rhod-
amine-conjugated goat anti-rabbit and anti-mouse
antibodies were from Jackson (West Grove, PA).
FITC-conjugated goat anti-rabbit and anti-mouse
antibodies were from Cappel (Durham, NC).
2.2. Cell cultures
ECV304 cells [8] were grown in RPMI 1640 with
10% FCS. CHO cells were grown in DMEM with
10% FCS. HUVEC were isolated from umbilical
cords and grown on gelatin-coated dishes in RPMI
1640, supplemented with 10% FCS, 90 mg/l heparin
and 15 mg/l ECGS, as previously described [6].
2.3. Generation of pro-vWf-expressing cell lines
A pro-vWf expression vector (pCMV4-pro-vWf,
kindly provided by Dr. D.D. Wagner, Boston,
MA) was generated by inserting the wild-type, full-
length human pro-vWf coding sequence (9 kb) into
the unique EcoRI site of the pCMV4 expression vec-
tor as described [12]. ECV304 cells were transfected
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with the pCMV4-pro-vWf using the calcium phos-
phate method as described by the manufacturer
(CellPhect kit, Pharmacia Biotech, Uppsala, Swe-
den). For stable transfection, the pCMV4-pro-vWf
vector was co-transfected with a neomycin resistance
plasmid (pSVneo). The cells were grown in RPMI
1640+10% FCS, and neomycin-resistant clones were
selected by culture in the presence of 250 Wg/ml G418
(Calbiochem, La Jolla, CA or Gibco-BRL, Cergy
Pontoise, France). Pro-vWf-expressing clones were
identi¢ed by measuring propeptide immunoreactivity
into the conditioned medium by ELISA as previously
described [11]. One of several positive clones, desig-
nated ECV304-vWf, was expanded for further study.
CHO cells were transfected with the pcDNA3vWf
vector. This vector was obtained by inserting the
human pro-vWf sequence into the EcoRI cloning
site of the pcDNA3 vector (Invitrogen, the Nether-
lands). In this new vector, the pro-vWf cDNA is ex-
pressed from the CMV promoter and the neomycin
resistance gene from the SV40 promoter. After trans-
fection using the calcium phosphate method, neomy-
cin-resistant clones were selected in the presence of
800 Wg/ml of G418. Pro-vWf expression was deter-
mined by measuring vWf immunoreactivity in the
conditioned medium by ELISA. One positive clone,
called CHO-vWf4, was expanded for further study.
2.4. vWf immunoprecipitation and electrophoresis
The various cell types were cultured to con£uency
and metabolically labeled with 40 WCi/ml
[35S]cysteine and [35S]methionine (Promix, Amer-
sham, Little Chalfont, UK) for 48 h in methionine-
and cysteine-de¢cient RPMI 1640. The labeling me-
dium was collected and supplemented with Tris
(50 mmol/l, pH 8.0), EDTA (2 mmol/l), PMSF
(1 mmol/l), iodoacetic acid (1 mmol/l) and N-meth-
yl-maleimide (1 mmol/l). Pro-vWf and vWf were im-
munoprecipitated from the samples with an anti-vWf
antiserum preadsorbed to protein A-Sepharose. Re-
duced proteins were separated by SDS-PAGE on a
6% gel. The gels were processed using a Phosphor-
Imager (Molecular Dynamics, Sunnyvale, CA).
2.5. Secretion studies
Con£uent ECV304-vWf cells grown in 6-well
dishes were washed three times and preincubated in
1 ml Krebs^Ringer-bicarbonate-HEPES bu¡er
(KRBH, 120 mmol/l NaCl, 4.75 mmol/l KCl, 1.2
mmol/l KH2PO4, 0.6 mmol/l MgSO4, 1.2 mmol/l
CaCl2, 25 mmol/l NaHCO3, 25 mmol/l HEPES, pH
7.4) supplemented with 0.1% bovine serum albumin
for 10 min at 37‡C. After a fourth wash, cells were
incubated in 1 ml KRBH with the di¡erent agents
for 30 min. All pharmacological agents were directly
dissolved in incubation medium, only forskolin and
IBMX were dissolved in DMSO. The ¢nal concen-
tration of DMSO in the incubation medium did not
exceed 0.2%, a concentration which has no e¡ect on
vWf release. After 30 min, the conditioned medium
was collected and cleared of cell debris by centrifu-
gation. The cells were lysed by freeze^thawing in
20 mM Tris, pH 8.0, 5 mM EDTA, and 1% Triton
X-100. vWf was measured in the supernatants and
lysates by ELISA as previously described [6]. Total
protein content in the cell lysates was determined
using the BCA assay (Pierce, Rockford, IL).
2.6. Immuno£uorescence analysis
Cells grown on glass coverslips were ¢xed in form-
aldehyde (3.7%) in phosphate-bu¡ered saline (PBS:
10 mmol/l NaH2PO4/Na2HPO4, 136 mmol/l NaCl,
2.7 mmol/l KCl, pH 7.4), washed with PBS,
quenched for 20 min with 0.27% NH4Cl/0.38% gly-
cine in PBS and permeabilized with Triton X-100
(0.5%) in PBS. vWf was visualized by sequential in-
cubations with puri¢ed rabbit anti-vWf antibodies
(2 Wg/ml) and rhodamine-conjugated goat anti-rabbit
antibodies (1:200). vWf-propeptide was visualized by
incubations with the monoclonal antibody 3H4 (2 Wg/
ml) and with FITC-conjugated goat anti-mouse
(1:100). For vWf and t-PA double labeling, cells
were incubated with rabbit anti-vWf (2 Wg/ml) and
monoclonal anti-t-PA (ESP-4, 10 Wg/ml) antibodies
and then with FITC-conjugated goat anti-rabbit (1/
100) and rhodamine-conjugated goat anti-mouse (1/
100) antibodies. The coverslips were mounted with
polyvinyl alcohol and observed with a Zeiss Axiovert
microscope equipped with a Hamamatsu digitalized
camera connected to an acquisition and deconvolu-
tion program (Openlab, Improvision, Coventry,
UK). We veri¢ed that signals from the rhodamine-
conjugated antibodies were not visible in the FITC
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channel and vice versa. We also veri¢ed the absence
of cross-reactivity between rabbit antibodies and
anti-mouse antibodies and between mouse antibody
and anti-rabbit antibodies.
2.7. Cell infection with recombinant adenovirus
expressing t-PA
ECV304 and ECV304-vWf cells were grown to
subcon£uence on glass coverslips and infected with
a recombinant adenovirus expressing tissue-type
plasminogen activator (AdCMVt-PA [13]; a kind
gift from Dr. R. Gerard, Ann Arbor, MI) at a titer
of 108 PFU/ml for 1 h at 37‡C in 0.3 ml RPMI 1640/
10% FCS. One hour after infection, the cells were
washed and maintained in culture for a further 72 h
prior to ¢xation and immuno£uorescence analysis.
3. Results and discussion
To create a suitable model cell system for the
study of vWf storage and exocytosis we used the
endothelial cell line ECV304 which is a spontane-
ously transformed and easily transfectable cell line
established from HUVEC [8]. In contrast with HU-
VEC, ECV304 cells do not express pro-vWf when
analyzed either by immuno£uorescence or by immu-
noprecipitation with anti-vWf antibodies (data not
shown). In preliminary experiments, ECV304 cells
were transiently transfected with the pCMV4-pro-
vWf vector. Indirect immuno£uorescence with anti-
vWf antibodies revealed a granular pattern highly
reminiscent of WPb (not shown). We next generated
a stable cell line by co-transfection of ECV304 cells
with the pCMV4-pro-vWf vector and a neomycin
resistance vector. Neomycin-resistant clones were
screened for the release of propeptide immunoreac-
tivity into the culture medium. One such clone,
ECV304-vWf was expanded for further characteriza-
tion. We also transfected pro-vWf cDNA in CHO
cells, which are known to have no pathway for regu-
lated secretion and generated a cell line that stably
expresses vWf called CHO-vWf4.
The content of vWf in ECV304-vWf cells was
measured by ELISA in cell lysates. It varied from
14 to 56 ng/mg cell protein (range of ¢ve independent
experiments), without an obvious correlation with
cell passage number. This content represents approx-
imately 2^7% of the vWf content of HUVEC. Pro-
vWf expression was veri¢ed by immunoprecipitation
from conditioned media and SDS-PAGE (Fig. 1). In
both ECV304-vWf and CHO-vWf4 cells, we ob-
served two typical bands with an apparent MW of
260 and 220 kDa, which co-migrated with pro-vWf
and mature vWf isolated from HUVEC, con¢rming
that full-length pro-vWf is expressed and correctly
processed in both transfected cell lines. This experi-
ment indicated a much higher release of pro-vWf
from CHO-vWf4 cells than from ECV304-vWf cells.
Indeed, after adjustment for cell load and densito-
metric scanning, we found that release from CHO-
vWf4 was at least ¢ve times higher than from HU-
VEC, while release from ECV304-vWf cells was
Fig. 1. Analysis of vWf produced by HUVEC and the pro-
vWf-expressing ECV304-vWf and CHO-vWf4 cell lines. Con£u-
ent cells were cultured for 48 h in the presence of 40 WCi/ml
[35S]cysteine and [35S]methionine. vWf was immunoprecipitated
from the conditioned medium of HUVEC (lanes 1 and 3),
CHO-vWf4 (lane 2) and ECV304-vWf (lane 4) cells (using start-
ing material in an amount in ratio of 1:1:3) and was resolved
by reduced 6% SDS-PAGE. Two bands of 260 and 220 kDa
(arrowheads) corresponding to pro-vWf and mature vWf were
identi¢ed in all three cell types. Densitometric scanning of the
bands indicated that pro-vWf release from ECV304-vWf cells is
10^20 times lower than from HUVEC. In contrast, release from
CHO-vWf4 cells was more than ¢ve times higher than from
HUVEC. The two bars at the right indicate the migration of
the 200 and 97 kDa MW markers.
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found to be approximately 20 times lower than from
HUVEC. The large di¡erence in pro-vWf expression
level is unexplained. In HUVEC, pro-vWf cleavage is
thought to occur in the trans-Golgi network and has
been attributed to the enzyme furin (also called
PACE) [14,15]. The pro-vWf/mature vWf ratio in
HUVEC indicates that more than 90% of pro-vWf
is cleaved. This ratio was more than 70% in ECV304-
vWf and CHO-vWf4 cells, indicating that correct
pro-vWf cleavage is largely preserved in both cell
lines.
The putative vWf storage pool in ECV304-vWf
cells was investigated by immuno£uorescence analy-
sis. These cells were found to contain elongated gran-
Fig. 2. Localization of vWf in HUVEC, the pro-vWf-expressing ECV304-vWf and CHO-vWf4 cell lines. Precon£uent ECV304-vWf
cells (A,B), HUVEC (C) and CHO-vWf4 cells (D) grown on glass coverslips were ¢xed and processed for immuno£uorescence analysis
for vWf. (A) in ECV304-vWf cells, one to 20 vWf-positive granules were seen in approximately half of the cells. A was deliberately
overexposed to better illustrate the weak perinuclear staining, resulting in the blurring of the rod-shaped aspect of the granules.
B shows an enlarged view of an ECV304-vWf cell, where the granules have the typical elongated shape of Weibel^Palade bodies that
are shown in HUVEC for comparison (C). Note the very low perinuclear staining in ECV304-vWf cells compared to HUVEC, which
is in accordance with the lower level of vWf expression in these cells. Staining of CHO-vWf4 cell for vWf revealed abundant extracel-
lular vWf deposits (due to vWf’s adhesive properties) confusing the visualization of intracellular structures; for these cells, a staining
with anti-propeptide antibodies is shown instead (D). No granular structures were seen in CHO-vWf4 cells in spite of intense perinu-
clear staining. Scale bars: 20 Wm.
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ules stained by anti-vWf antibodies (Fig. 2A,B) and
therefore identi¢ed as WPb. Half of the cells had
between one and twenty vWf-positive granules (Fig.
2A), with a minority of cells containing a much larg-
er number of granules (Fig. 2B). Staining of HUVEC
with anti-vWf antibodies is shown for comparison
(Fig. 2C). The weak staining for vWf in ECV304-
vWf cells is in accordance with the low level of ex-
pression of pro-vWf in this cell line. Similar results
were obtained using anti-propeptide antibodies (not
shown). In double labeling experiments, the antibody
BB6, speci¢c for the lysosomal membrane protein
LAMP-1, did not stain the vWf-positive granules,
arguing against the possibility that these granules
represent a lysosomal degradation compartment
(not shown). These results indicate that ECV304-
vWf cells possess the molecular mechanism(s) re-
quired for vWf storage. In CHO-vWf4 cells, we ob-
served a strong perinuclear staining for vWf, indica-
tive of a high level of expression. No vWf-positive
granules were observed in these cells (Fig. 2D). Giv-
en the much higher level of expression of pro-vWf in
CHO-vWf4 cells than in ECV304-vWf cells, we may
conclude that a high level of pro-vWf expression and
a correct processing are by themselves not su⁄cient
to promote vWf storage.
To determine whether the WPb-like structures of
ECV304-vWf cells are indeed functional secretory
granules, we performed acute vWf release experi-
ments (Fig. 3). Numerous earlier reports have shown
that acute release of vWf from HUVEC is induced
by thrombin, A23187, and forskolin/IBMX [5^7,16].
ECV304-vWf cells were incubated for 30 min with
these agonists at the concentrations routinely used
to induce maximal vWf secretion in HUVEC. vWf
release into the conditioned medium was measured
by ELISA and expressed as a percentage of cell con-
tent. We observed a signi¢cant increase in vWf re-
lease in response to the calcium ionophore A23187
(control, 4.8 þ 1.1%; A23187, 11.3 þ 2.7%; means þ
S.E., P = 0.0012, n = 5). The response to A23187
was further enhanced to 15.2 þ 2.8% by co-incuba-
tion with forskolin and IBMX added to raise cellular
cAMP content. In contrast, ECV304-vWf cells did
not respond to forskolin. Incubation with 0.5 U/ml
thrombin with or without foskolin/IBMX caused a
weak, but signi¢cant, increase in vWf release (throm-
bin alone 6.3 þ 1.9%, P = 0.02) which is lower than
what can be obtained with HUVEC. Taken together,
these results indicate that ECV304-vWf cells can
acutely release vWf and that the secretory response
to calcium ionophore is preserved. The rapidity of
the response (less than 30 min) suggests release
from a preformed store. Thus ECV304-vWf cells
are a promising model for the study of the molecular
mechanisms of calcium-mediated exocytosis.
Acute release of vWf by EC is often accompanied
by the acute release t-PA. This suggests that t-PA
and vWf are stored either in the same granules or
in distinct granules that respond to the same stimuli.
Studies on the localization of t-PA are made di⁄cult
by the low level of t-PA in EC. The intracellular
storage site for t-PA is still a matter of debate. We
reported recently that HUVEC can store t-PA in
WPb [9]. In contrast, Emeis et al. [10] presented evi-
dence for storage of t-PA in granules di¡erent from
WPb. We took advantage of the two ECV304 cell
lines presented in this study to investigate the contri-
bution of WPb to t-PA storage. In preliminary im-
Fig. 3. Agonist-induced acute vWf release from the pro-vWf-ex-
pressing ECV304-vWf cell line. Con£uent cells were incubated
for 30 min at 37‡C in KRBH alone or in KRBH containing
100 Wmol/l IBMX and 10 Wmol/l forskolin (For), 0.5 U/ml
thrombin (Thr), 10 Wmol/l A23187 (A23), or a combination of
these agonists. vWf release was measured by ELISA. Results
are expressed as a percentage of cell content and as means þ
S.E. of ¢ve experiments. *P6 0.01 by Student’s paired t-test.
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muno£uorescence studies, we did not detect t-PA
either in ECV304 cells or in ECV304-vWf cells
(data not shown). To increase the expression of t-
PA in these cells, we used a t-PA recombinant ad-
enovirus that e⁄ciently led to the expression of t-PA
in EC [9,13]. In the vWf-negative ECV304 cells, ad-
enovirus-mediated t-PA expression resulted in the
appearance of a strong perinuclear signal for t-PA
and a di¡use staining throughout the cytoplasm
(Fig. 4A). In the vWf-positive ECV304-vWf cells in-
fected with the t-PA-recombinant adenovirus, t-PA
was found in elongated granules (Fig. 4C) that also
stored vWf (Fig. 4D) and were therefore identi¢ed as
WPb. Thus, restoration of WPb in the ECV304 cell
line led to the storage of t-PA in these secretory
granules. These results are in agreement with our
previous ¢ndings that t-PA can be stored in the
WPb of HUVEC [9]. As to the nature of the t-PA
staining throughout the cytoplasm of adenovirus-t-
PA infected ECV304 cells, we have no clear morpho-
logical criteria to discriminate whether the staining
corresponds to the endoplasmic reticulum or to t-PA
storage granules reminiscent of those described by
Emeis et al. [10] or to both. A minimal conclusion
Fig. 4. Localization of t-PA and vWf in the ECV304 and pro-vWf-expressing ECV304-vWf cell lines. ECV304 cells (A,B) and
ECV304-vWf cells (C,D) were infected with a t-PA-expressing adenovirus. The cells were ¢xed 72 h after infection and subjected to
double label immuno£uorescence analysis for t-PA (A,C) and vWf (B,D). In ECV304 cells, t-PA was detected in the perinuclear area
and in a di¡use pattern throughout the cytoplasm (A) whereas no signal was observed for vWf as expected (B). In ECV304-vWf cells,
t-PA was detected in elongated granules (C); these granules were also stained by anti-vWf antibodies (D) and therefore identi¢ed as
Weibel^Palade bodies; the arrows point to Weibel^Palade bodies labeled by both anti-t-PA and anti-vWf antibodies. Scale bar: 20
Wm.
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from our observations is that t-PA and vWf are not
mutually exclusive for storage in WPb.
In summary, restoration of vWf expression in a
HUVEC-derived vWf-de¢cient cell line was su⁄cient
to restore the formation of functional WPb. To our
knowledge, this is the ¢rst demonstration of a func-
tional, releasable storage pool induced by pro-vWf
transfection. The transfectable vWf-expressing endo-
thelial ECV304-vWf cell line should provide a valua-
ble tool for the molecular dissection of the mecha-
nisms responsible for vWf storage and calcium-
dependent release as well as for the study of endo-
thelial storage mechanisms for t-PA or other secreted
proteins.
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